MENU
BCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioCryst Pharmaceuticals (BCRX) Ownership - Who owns BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
4505 Emperor Boulevard
Phone
+1 919 859-1302
Employees
536
Web
https://www.biocryst.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
2.11B
P/E Ratio
N/A
Total Cash
295.09M
Projected Growth
N/A
Total Debt
794.99M
Revenue
503.49M
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash/Share
1.41
Total Debt/Equity
N/A
Revenue/Share
2.41 USD as % of share price
Fundamentals
BCRX
Capitalization
2.11B
P/E Ratio
N/A
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash
295M
Total Cash/Share
1.41
Total Debt
795M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.41%
Revenue
503M
ROE
N/A
Book Value
-451.93M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.09M
Current Ratio
2.93
Current Revenue Per Employee
250920.69
Dividends Per Share - Security
N/A
EBITDA
47.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.86
Revenue To Assets
-11.28
Shares Held By Institutions
1.82B
Shares Outstanding - Current
209M
Total Liabilities
932M
Total Volume MTD
N/A
Value
1
Gain YTD
33.777
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of small molecule pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4505 Emperor Boulevard
Phone
+1 919 859-1302
Employees
536
Web
https://www.biocryst.com